Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Dialysis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Dialysis
    Fibroblast Growth Factor Indicates Death Risk in Dialysis Patients - (DGNews)
    Single Lot of Epoetin Alfa Recalled Due to Damaged Vials - (DGNews)
    TopAbstracts in Dialysis 08/05/2008 - (DGNews)
    High Alkaline Phosphatase Levels May Signal Death Risk in Dialysis Patients - (DGNews)
    TopAbstracts in Dialysis 07/22/2008 - (DGNews)

    News archive

     Recent webcasts/CME - Dialysis

    Webcasts/CME archive

     Recent cases - Dialysis
      A Case of Necrotizing Pancreatitis in CAPD
      The Effect of a Large Proximal Haemodialysis A-V Fistula on Weaning off Cardiopulmonary Bypass
      Fuchs' Heterochromic Uveitis Associated with Retinal Break or Dialysis
      Pregnancy in Dialysis Patients: A Case Series
      Hypercalcemia after Transplant Nephrectomy in a Hemodialysis Patient: A Case Report

      Cases archive
        




      my personal edition > dialysis > news
      divider

        E-Mail this DGNews to a colleague

      DGNews


      Hemodialysis Causes Antioxidant Loss Leading to Long-Term Complications

      NEW YORK, NY -- April 8, 2005 -- An article published in Hemodialysis International discusses the role of oxidative stress (OS) in dialysis patients, an imbalance which can result in long-term health problems. Potential therapeutic options to restore balance in patients are also reviewed.

      Oxidative stress, an imbalance between toxic compounds and defense mechanisms, and prevalent in the dialysis process, has been linked to numerous adverse complications in end-stage renal disease (ESRD) patients. The imbalance is caused by the overproduction of reactive oxygen species (ROS), or toxic compounds, and lack of antioxidants to fight these toxins. In fact, the hemodialysis process can cause loss of these necessary antioxidants.

      Many ESRD and hemodialysis patients are in a state of chronic inflammation induced by the dialysis process which further enhances oxidative stress. This state is strongly associated with long-term complications such as cardiovascular disease, malnutrition, poor outcome and low survival.

      "It is important to prevent reactive oxygen species production by improving the biocompatibility of the hemodialysis system," states Dr. Jean-Paul Cristol, corresponding author. Antioxidant supplementation and ROS modulation by specific or non-specific drugs, such as statins, are possible solutions outlined in the article.

      "Correction of OS imbalance appears to be a basic requisite to prevent complications in long-term dialysis patients" and is "a promising avenue of research."



      SOURCE: Blackwell Publishing Ltd.



      E-Mail this DGNews to a colleague   To print, use this version






      All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send